Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-000438-38Phase 4Completed
Phase 4, open-label, single-arm trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Primary endpoint: Plasma concentrations of lopinavir. Started Mar 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-000438-38.